Clinical Trial Update: Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating vorinostat in combination with etoposide in pediatric patients under 21 with refractory solid tumors, completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcomas
• Solid Tumors

Drugs mentioned

• Etoposide (Etoposide)
• Vorinostat (vorinostat)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Solid Tumors, Relapsed/Refractory Sarcomas | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-11-18